Legislative history Best Pharmaceuticals for Children Act : (P.L. 107-109, 115 Stat. 1408) /

Similar Items

• Better pharmaceuticals for children : assessment and opportunities : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, first session on examining the impact of the pediatric exclusivity provision of the better pharmaceuticals for children act, which grants a pharmaceutical company an additional 6 months of market exclusivity for new or marketed drugs in exchange for conducting pediatric studies requested by the Food and Drug Administration, May 8, 2001.
  Published: (2001)
• Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.
  Published: (2001)
• Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001
  Published: (2001)
• Johnson & Johnson's recall of Children's Tylenol and other children's medicines. hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, second session.
  Published: (2011)
• Johnson & Johnson's recall of Children's Tylenol and other children's medicines : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, second session
  Published: (2011)